About Orthofix Medical Inc.
https://www.orthofix.comOrthofix Medical Inc. operates as a medical device and biologics company in the United States, Italy, Germany, France, the United Kingdom, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics.
CEO
Massimo Calafiore
Compensation Summary
(Year 2024)
ETFs Holding This Stock
Summary
Showing Top 3 of 97
Ratings Snapshot
Rating : C
Most Recent Analyst Grades
Grade Summary
Showing Top 4 of 4
Price Target
Institutional Ownership
ENGINE CAPITAL MANAGEMENT, LP
Shares:4.25M
Value:$60.9M
RUBRIC CAPITAL MANAGEMENT LP
Shares:3.72M
Value:$53.29M
PARADIGM CAPITAL MANAGEMENT INC/NY
Shares:3.34M
Value:$47.89M
Summary
Showing Top 3 of 172
About Orthofix Medical Inc.
https://www.orthofix.comOrthofix Medical Inc. operates as a medical device and biologics company in the United States, Italy, Germany, France, the United Kingdom, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $205.63M ▲ | $165.57M ▲ | $-22.8M ▼ | -11.09% ▼ | $-0.57 ▼ | $-3.06M ▼ |
| Q2-2025 | $203.12M ▲ | $155.54M ▼ | $-14.08M ▲ | -6.93% ▲ | $-0.36 ▲ | $7.72M ▲ |
| Q1-2025 | $193.65M ▼ | $170.49M ▲ | $-53.09M ▼ | -27.42% ▼ | $-1.35 ▼ | $-11.95M ▼ |
| Q4-2024 | $215.66M ▲ | $160.32M ▲ | $-29.15M ▼ | -13.51% ▲ | $-0.75 ▼ | $12.54M ▲ |
| Q3-2024 | $196.61M | $153.95M | $-27.39M | -13.93% | $-0.71 | $-4.64M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $65.95M ▲ | $832.61M ▼ | $390.12M ▲ | $442.49M ▼ |
| Q2-2025 | $65.61M ▲ | $837.16M ▲ | $378.81M ▲ | $458.35M ▲ |
| Q1-2025 | $57.95M ▼ | $823.14M ▼ | $364.85M ▼ | $458.29M ▼ |
| Q4-2024 | $83.24M ▲ | $893.29M ▲ | $390.17M ▲ | $503.12M ▼ |
| Q3-2024 | $30.05M | $867.87M | $341.95M | $525.92M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $-22.8M ▼ | $12.4M ▲ | $-9.89M ▼ | $-5.15M ▼ | $-2.74M ▼ | $2.5M ▼ |
| Q2-2025 | $-14.08M ▲ | $11.64M ▲ | $-7.1M ▼ | $2.64M ▲ | $8.24M ▲ | $4.53M ▲ |
| Q1-2025 | $-53.09M ▼ | $-18.39M ▼ | $-6.74M ▼ | $-651K ▼ | $-25.29M ▼ | $-25.13M ▼ |
| Q4-2024 | $-29.15M ▼ | $23.73M ▲ | $-1.14M ▲ | $31.49M ▲ | $53.18M ▲ | $15.2M ▲ |
| Q3-2024 | $-27.39M | $11.67M | $-5.86M | $-2.46M | $3.69M | $5.86M |
Revenue by Products
| Product | Q4-2024 | Q1-2025 | Q2-2025 | Q3-2025 |
|---|---|---|---|---|
 Global Orthopedics | $40.00M ▲ | $30.00M ▼ | $30.00M ▲ | $30.00M ▲ |
 Global Spine | $180.00M ▲ | $160.00M ▼ | $170.00M ▲ | $170.00M ▲ |
Revenue by Geography
| Region | Q4-2024 | Q3-2025 | Q2-2025 | Q1-2025 |
|---|---|---|---|---|
 Brazil | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
 FRANCE | $10.00M ▲ | $0 ▼ | $0 ▲ | $0 ▲ |
 GERMANY | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
 ITALY | $10.00M ▲ | $10.00M ▲ | $10.00M ▲ | $10.00M ▲ |
 Other Countries | $30.00M ▲ | $20.00M ▼ | $20.00M ▲ | $20.00M ▲ |
CEO
Massimo Calafiore
Compensation Summary
(Year 2024)
ETFs Holding This Stock
Summary
Showing Top 3 of 97
Ratings Snapshot
Rating : C
Most Recent Analyst Grades
Grade Summary
Showing Top 4 of 4
Price Target
Institutional Ownership
ENGINE CAPITAL MANAGEMENT, LP
Shares:4.25M
Value:$60.9M
RUBRIC CAPITAL MANAGEMENT LP
Shares:3.72M
Value:$53.29M
PARADIGM CAPITAL MANAGEMENT INC/NY
Shares:3.34M
Value:$47.89M
Summary
Showing Top 3 of 172